Diseases, Conditions, Syndromes

2009 to 2018 saw increase in incidence of NAFLD in children

(HealthDay)—From 2009 to 2018, there was an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) among children, although many still remain undiagnosed, according to a study published online Nov. 19 in ...

Medications

Drug approved to treat tenosynovial giant cell tumor

(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and Drug Administration announced.

Obstetrics & gynaecology

Stillbirth risk up with high serum bile acids in pregnancy

(HealthDay)—The risk of stillbirth is increased in women with intrahepatic cholestasis of pregnancy when serum bile acids concentrations are ≥100 µmol/L or more, according to a review published in the March 2 issue of ...

Diseases, Conditions, Syndromes

Zinc effective in pediatric presymptomatic Wilson disease

(HealthDay)—For young children with presymptomatic Wilson disease, zinc monotherapy is safe and effective, according to a study published online April 28 in the Journal of Gastroenterology and Hepatology.

Cardiology

Baseline ALT, AST frequently assessed with statin initiation

(HealthDay)—Most Medicare fee-for-service beneficiaries with dyslipidemia who initiate statins undergo baseline alanine aminotransferase (ALT) and aspartate aminotransferase (AST) testing, according to a study published ...

Diseases, Conditions, Syndromes

Elevated liver enzymes common in severe anorexia nervosa

(HealthDay)—For adults with severe anorexia nervosa (AN), elevated liver enzymes are relatively common and are associated with lower body mass index (BMI) and hypoglycemia, according to research published online Sept. 8 ...

Diseases, Conditions, Syndromes

Consider false-positives when test results don't add up

(HealthDay)—Physicians should weigh patient history and include the possibility of false-positive test results when considering differential diagnoses, according to a perspective piece published online Dec. 15 in JAMA Internal ...

Diseases, Conditions, Syndromes

Sex, age at presentation affect cirrhosis response to therapy

(HealthDay)—Among patients with primary biliary cirrhosis (PBC), sex and age at presentation affect the response to ursodeoxycholic acid (UDCA), according to a study published in the March issue of Gastroenterology.

page 1 from 2